Table 7.
Outcome of Parainfluenza Virus-Associated Pneumonia Among Hospitalized Adult Bone Marrow Transplant Recipients and Patients with Leukemia
| Mortality (%) |
||
|---|---|---|
| Therapya | BMT (n = 26) | Leukemia (n = 6) |
| Earlyb | 0/3 (0) | — |
| Lateb | 2/2 (100) | — |
| None | 8/21 (38) | 4/6 (66) |
BMT = bone marrow transplant.
a
Therapy consisted of aerosolized ribavirin (20 mg/mL for 18 h/day) and intravenous immunoglobulin (500 mg/kg every other day for varying durations).
b
Therapy was classified as “early” or “late” depending on whether it was initiated >24 h or <24 h prior to respiratory failure requiring mechanical ventilation, respectively.